Background Severe patients with 2019 novel coronavirus (2019-nCoV) pneumonia
progressed rapidly to acute respiratory failure. We aimed to evaluate the definite efficacy …

Objectives This study aimed to observe the efficacy of corticosteroids in non-severe COVID-
19 pneumonia. Methods A retrospective study based on propensity score matching was …

Background There is no proven antiviral or immunomodulatory therapy for coronavirus
disease 2019 (COVID-19). The disease progression associated with the proinflammatory …

Background: There is still no clinical evidence available to support or to oppose
corticosteroid treatment for coronavirus disease 2019 (COVID-19) pneumonia. Objective: To …

Background: At the end of 2019, a novel coronavirus outbreak causative organism has been
subsequently designated the 2019 novel coronavirus (2019-nCoV). The effectiveness of …

Objective To assess the efficacy of corticosteroids in patients with coronavirus disease 2019
(COVID-19). Methods A multicentre observational study was performed from 22 February …

The aim was to investigate the effectiveness of glucocorticoid therapy in patients with COVID-
19. A systematic search of the literature across nine databases was conducted from …

Background: At the end of 2019, a novel coronavirus outbreak emerged in Wuhan, China,
and its causative organism has been subsequently designated the 2019 novel coronavirus …

BACKGROUND Corticosteroids are widely used in patients with COVID 19, although their
benefit-to-risk ratio remains controversial. METHODS Patients with severe COVID-19 …

Method: A retrospective cohort study based on propensity score analysis was designed to
explore the effects of corticosteroid on several clinical outcomes. Results: One hundred thirty …